Abstract
Oral immunotherapy (OIT) with Peanut (Arachis hypogaea) allergen powder-dnfp (PTAH) is a promising treatment to desensitize peanut allergic patients. Our aim was to assess changes in IgE and IgG4 binding to peanut allergens and their epitopes recognized by peanut allergic patients undergoing OIT with PTAH in the US.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
